Clinical Trial Update: DCVax Plus Poly ICLC in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of DCVax Plus Poly ICLC in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DCVax Plus Poly ICLC

Snippet

Sponsor: Rockefeller University | Conditions: HIV-1 Infection, HIV Infection | Phase 1 | Status: COMPLETED